中华皮肤科杂志
中華皮膚科雜誌
중화피부과잡지
Chinese Journal of Dermatology
2014年
6期
433-434
,共2页
陈静%李振鲁%朱雪峰%吴华娟%王莉%王豫平
陳靜%李振魯%硃雪峰%吳華娟%王莉%王豫平
진정%리진로%주설봉%오화연%왕리%왕예평
硬化萎缩性苔藓,外阴%氨基酮戊酸%光化学疗法
硬化萎縮性苔蘚,外陰%氨基酮戊痠%光化學療法
경화위축성태선,외음%안기동무산%광화학요법
Lichen sclerosus et atrophicus of the vulva%Aminolevulinic acid%Photochemotherapy
目的 观察氨基酮戊酸光动力疗法治疗女阴硬化萎缩性苔藓的疗效和安全性.方法 采用开放性,非对照性临床研究,受试者每两周进行1次氨基酮戊酸光动力治疗,治疗2~4次,于治疗前,治疗后2、4、8周各随访1次,进行疗效和安全性评价.结果 共有38例女阴硬化萎缩性苔藓的患者纳入疗效分析.治疗结束后,总有效率为81.6%(31/38).症状/体征总分在治疗后第2、4、8周分别为17.6±10.18、11.6±8.35、7.6±5.93,均明显低于治疗前(29.3±9.17),经t检验,差异均有统计学意义(t值分别为5.26、8.80、12.22,均P< 0.01).其他疗效评估指标包括皮损面积、白斑、萎缩、糜烂/皲裂、瘙痒评分,在治疗后第2、4、8周(萎缩自第8周开始)均较治疗前改善明显,差异均有统计学意义(均P< 0.05).氨基酮戊酸光动力疗法不良反应主要表现为治疗局部皮肤灼热感,其中16%(6/38)的患者在第1次治疗时诉疼痛明显.结论 氨基酮戊酸光动力疗法治疗女阴硬化萎缩性苔藓,起效快,疗效确切.
目的 觀察氨基酮戊痠光動力療法治療女陰硬化萎縮性苔蘚的療效和安全性.方法 採用開放性,非對照性臨床研究,受試者每兩週進行1次氨基酮戊痠光動力治療,治療2~4次,于治療前,治療後2、4、8週各隨訪1次,進行療效和安全性評價.結果 共有38例女陰硬化萎縮性苔蘚的患者納入療效分析.治療結束後,總有效率為81.6%(31/38).癥狀/體徵總分在治療後第2、4、8週分彆為17.6±10.18、11.6±8.35、7.6±5.93,均明顯低于治療前(29.3±9.17),經t檢驗,差異均有統計學意義(t值分彆為5.26、8.80、12.22,均P< 0.01).其他療效評估指標包括皮損麵積、白斑、萎縮、糜爛/皸裂、瘙癢評分,在治療後第2、4、8週(萎縮自第8週開始)均較治療前改善明顯,差異均有統計學意義(均P< 0.05).氨基酮戊痠光動力療法不良反應主要錶現為治療跼部皮膚灼熱感,其中16%(6/38)的患者在第1次治療時訴疼痛明顯.結論 氨基酮戊痠光動力療法治療女陰硬化萎縮性苔蘚,起效快,療效確切.
목적 관찰안기동무산광동력요법치료녀음경화위축성태선적료효화안전성.방법 채용개방성,비대조성림상연구,수시자매량주진행1차안기동무산광동력치료,치료2~4차,우치료전,치료후2、4、8주각수방1차,진행료효화안전성평개.결과 공유38례녀음경화위축성태선적환자납입료효분석.치료결속후,총유효솔위81.6%(31/38).증상/체정총분재치료후제2、4、8주분별위17.6±10.18、11.6±8.35、7.6±5.93,균명현저우치료전(29.3±9.17),경t검험,차이균유통계학의의(t치분별위5.26、8.80、12.22,균P< 0.01).기타료효평고지표포괄피손면적、백반、위축、미란/군렬、소양평분,재치료후제2、4、8주(위축자제8주개시)균교치료전개선명현,차이균유통계학의의(균P< 0.05).안기동무산광동력요법불량반응주요표현위치료국부피부작열감,기중16%(6/38)적환자재제1차치료시소동통명현.결론 안기동무산광동력요법치료녀음경화위축성태선,기효쾌,료효학절.
Objective To estimate the efficacy and safety of 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) in the treatment of lichen sclerosus et atrophicus of the vulva.Methods An open and noncontrolled clinical study was performed.Forty-two patients were enrolled in this study and received ALA-PDT once every two weeks for 2 to 4 times.Follow-up visits were arranged at 2,4 and 8 weeks after initiation of treatment,and patients were evaluated at the baseline (before treatment) and all the follow-up time points for the efficacy and safety of treatment.Results Finally,38 patients completed the trial and 4 patients were lost to follow up.The total response rate was 81.6% (31/38) at the end of the treatment.The average symptom and sign score in these patients was significantly lower at 2,4 and 8 weeks after initiation of treatment than that before treatment (17.6 ± 10.18,11.6 ± 8.35 and 7.6 ± 5.93 vs.29.3 ± 9.17,t =5.26,8.80,12.22,respectively,all P < 0.01).A significant improvement was also observed in the other aspects,such as skin lesion area,hypopigmentation,erosion/rhagades and itching score at 2,4 and 8 weeks,as well as in skin atrophy at 8 weeks after initiation of treatment compared with those before treatment (all P < 0.05).Local burning sensation was the main adverse reaction to ALA-PDT,and 16% (6/38) of these patients complained of severe pain during the first treatment.Conclusion ALA-PDT shows favorable efficacy in patients with lichen sclerosus et atrophicus of the vulva with a rapid onset of action.